Topic: GlaxoSmithKline plc
LONDON (Reuters) - The number of head and neck cancers linked to a virus spread by oral sex is rising rapidly and suggests boys as well as girls should be offered protection through vaccination, doctors said Friday.Despite an overall slight decline in ...
Panel recommends a 2nd cervical cancer vaccine as alternative for girls and young womenA second kind of vaccine against cervical cancer may be added to the recommended list for girls and young women after a federal advisory panel voted Wednesday to support ...
WASHINGTON (Reuters) - A U.S. advisory panel has recommended the use of GlaxoSmithKline PLC's Cervarix vaccine to prevent cervical cancer in girls and young women, the company said on Wednesday.The Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices recommended ...
LOS ANGELES (Reuters) - GlaxoSmithKline Plc won U.S. approval on Friday to sell a cervical cancer vaccine for girls and young women, while a rival Merck & Co shot was cleared for preventing genital warts in males.Glaxo said the U.S. Food and ...
GlaxoSmithKline said Friday U.S. regulators approved its vaccine Cervarix to prevent the leading cause of cervical cancer in women, following a two-year delay.The approval from the Food and Drug Administration allows the British drug maker to compete against Merck's billion-dollar selling vaccine ...
WASHINGTON (Reuters) - GlaxoSmithKline Plc's bid to sell its Cervarix cervical cancer vaccine in the United States faced further delay on Tuesday and the company recalled a batch of the vaccine in Britain following a teenager's death.The U.S. Food and Drug Administration ...
LONDON (Reuters) - GlaxoSmithKline's cervical cancer vaccine Cervarix probably did not cause the death of a British teenager shortly after she was given the drug, a health official said on Tuesday. "At this stage the cause of this tragic death is unknown," ...
FDA delays decision on GlaxoSmithKline's cervical cancer vaccine CervarixThe Food and Drug Administration has delayed a decision on GlaxoSmithKline's vaccine for cervical cancer, according to the British drugmaker.The FDA was scheduled to announce its ruling Tuesday on whether to approve Cervarix, but ...
LONDON (Reuters) - A teenage British girl died after receiving a cervical cancer vaccine made by GlaxoSmithKline, but a link between the death and the drug has not yet been established, health officials said on Monday.The 14-year-old fell ill after she was ...
Glaxo's Cervarix vaccine moves towards US approval, Merck's Gardasil wins backing for boysDrugmaker Merck likely will face U.S. competition for its vaccine Gardasil, after federal experts recommended rival GlaxoSmithKline's Cervarix also be approved to prevent the virus that causes most cervical cancers.The ...
Photo Gallery
From Around the Web
Video Gallery
-
News Update: New Study Shows GlaxoSmithKline ...
A study in the Journal of the American Medical Association ...2010-06-28 -
GlaxoSmithKline Plc (GSK)
Everyone is looking for a nice save haven in these ...2008-02-13 -
GlaxoSmithKline up 1%; Pronova Biopharma Settles ...
GlaxoSmithKline plc (GSK) shares are up 0.89% to $38 ...2011-03-30
